bullish
EC Healthcare (2138 HK): An Attractive Idea with Insider Buying and Continued Business Recovery
228 Views25 Jan 2022 13:13
SUMMARY
- EC Healthcare (2138 HK)'s Chairman and CEO acquired 543,000 shares at an average price of HKD9.1943 per share, thereby increasing his stake to 61.17% of the issued share capital.
- H1FY22 and preliminary results for Q3FY22 shows continued business recovery. Medical services, which contributes 52.5% of total revenue continue to be the key growth driver.
- In January, EC Healthcare acquired 55% equity interest in Bayley & Jackson Dental Surgeons Limited for HKD129 million. Bayley & Jackson operates seven dental clinics in Hong Kong.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
x